黛力新与舍曲林联合应用对重度卒中后抑郁的疗效观察  

Effect of Deanxit Combined with Sertraline on Patients with Severe Post Stroke Depression

作　　者：孔令华[1] 贾彦丽[1] 樊建平[1] 赵华[1] 

机构地区：[1]滨州市中心医院,山东滨州251700

出　　处：《中外医学研究》2015年第13期11-12,共2页CHINESE AND FOREIGN MEDICAL RESEARCH

摘　　要：目的:观察黛力新与舍曲林联合应用对重度卒中后抑郁(post stroke depression,PSD)患者的临床疗效。方法:选择2013年1月-2014年10月笔者所在医院神经内科收治的符合重度卒中后抑郁的患者86例,按照随机数字表法分为治疗组与对照组。治疗组给予黛力新、舍曲林联合抗抑郁治疗,对照组仅给予黛力新治疗。访视治疗6个月,对治疗前,治疗1、3、6个月根据SDS抑郁评分量表进行计分。结果:治疗组患者计分改善情况明显优于对照组,差异有统计学意义(P<0.05)。结论:对重度卒中后抑郁患者,可考虑黛力新与舍曲林联合抗抑郁治疗。Objective：To observe the clinical effect of Deanxit combined with Sertraline on patients with severe post stroke depression（PSD）. Method：86 cases with severe PSD in neurology of our hospital from January 2013 to October 2014 were randomly divided into two groups.The treatment group was given Deanxit combined with Sertraline for antidepressant treatment,while the control group was only given Deanxit.Visit 6 months,the SDS depression rating scale were assessed before and after one month,three months and six months treatment.Result：The treatment group was better than the control group,there was statistical significance（P〈0.05）.Conclusion：Deanxit combined with Sertraline for antidepressant treatment are considerable on patients with severe PSD.

关 键 词：卒中后抑郁 黛力新 神经康复 

分 类 号：R743.3[医药卫生—神经病学与精神病学] R749.4[医药卫生—临床医学]